Screened 2026-09-08 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
Newmont holds its Markup at $127.09. The statistical read favours the sellers, held for 1 days.
As held on the ledger · 2026-09-08
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 1 days
Price at the screen
$127.09
Valuation
16.03 trailing · 12.60 forward price to earnings
Values screen
PASS· score 90.0
Beta
0.54
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
9.78%
Below 33%
Interest-bearing debt is just 9.8% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.30%
Below 33%
Cash held in interest-bearing accounts and securities is 0.3% of assets, under the one-third limit.
Pass
Receivables
15.26%
Below 49%
Money owed to the company is 15.3% of assets, under the 49% limit.
Pass
Revenue purity
0.94%
Below 5%
Only 0.9% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads STRONG OPPORTUNITY: it trades above our $109.11 fair value estimate, strong competitive moat, 15.10% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 14.1% above the base estimate.
Third-party analyst targets: 21 covering, consensus Buy. The average target sits +5% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Precious Metal Powerhouse with Ethical Shine
Imagine a company that controls the flow of the most desirable metal this side of a superhero's suit - gold. Newmont Corporation, with its extensive reach across nine countries, digs deep into the earth for precious metals, while maintaining a strong ethical stance that passes our filter. In the cyclical world of commodities, Newmont stands out not only for its robust revenue growth of 15% but also an impressive profit margin of 33%, suggesting efficiency and resilience in a volatile market. Its strong moat, underpinned by diverse operations and assets, fortifies its market position amidst industry fluctuations.
A forward P/E of 12.1x and a ROE of 26% are compelling, especially when paired with our fair value of $110.20, presenting a -14% margin of safety, a strong opportunity rating, and a consensus buy rating from 21 analysts with a median target of $131. However, given the cyclical nature of the industry, there's a potential value-trap to consider. The current low P/E might reflect peak earnings, a common pitfall in cyclical sectors, where a low multiple at the earnings peak can signal a warning rather than a bargain.
Risks are inherent in the gold business, with fluctuating commodity prices and geopolitical factors affecting operations across different countries. Despite these, Newmont's ethical pass and strong financials make it a standout in a sector where such attributes are as precious as the metals they mine. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NEM trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-24Markup · changed$127.64+42.3%Entry 11
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 42.3% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $132.
2026-07-23Distribution$89.70+0.0%Entry 10
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $140. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-22Distribution$89.70+0.0%Entry 9
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $140. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Distribution$89.70+0.0%Entry 8
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $140. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-20Distribution$89.70+0.0%Entry 7
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $140. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-19Distribution$89.70-10.0%Entry 6
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $140. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Distribution$99.71+0.0%Entry 5
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (90). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $140. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-17Distribution$99.71+0.0%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (90). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $140. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-16Distribution$99.71+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (90). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (21 analysts) rates it buy, with a mean price target of $140. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-03Distribution$99.71+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (90). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
